We are live on
!
Find out more
BCM
Brooktree Capital Management Portfolio holdings
AUM
$153M
1-Year Est. Return
14.06%
This Fund
S&P 500
This Quarter
Est. Return
+34.31%
1 Year Est. Return
+14.06%
3 Year Est. Return
+82.89%
5 Year Est. Return
+68.3%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$20M
(+23%)
Cap. Flow
-$1.78M
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
55.13%
Holding
104
New
–
Increased
11
Reduced
29
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$820K |
| 2 |
PAR Technology
PAR
|
+$337K |
| 3 |
Interactive Brokers
IBKR
|
+$289K |
| 4 |
AbbVie
ABBV
|
+$120K |
| 5 |
CVET
Covetrus, Inc. Common Stock
CVET
|
+$76K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$325K |
| 2 |
Biogen
BIIB
|
+$259K |
| 3 |
RTX Corp
RTX
|
+$192K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$121K |
| 5 |
Jefferies Financial Group
JEF
|
+$110K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.36% |
| 2 | Financials | 21.32% |
| 3 | Industrials | 15.68% |
| 4 | Healthcare | 15.17% |
| 5 | Consumer Discretionary | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abbott
ABT
$176B
| $1.44M | 1.35% |
15,704
-42
| -0.3% | -$3.8K |
|
|
CVET
27
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.18M | 1.11% |
65,936
+5,780
| +10% | +$76K |
|
28
S&P Global
SPGI
$121B
| $868K | 0.82% |
2,636
+27
| +1% | +$8.12K |
|
29
Cisco
CSCO
$442B
| $801K | 0.75% |
17,191
-120
| -0.7% | -$5.26K |
|
30
Lam Research
LRCX
$373B
| $782K | 0.74% |
24,190
| – | – |
|
31
3M
MMM
$85.1B
| $765K | 0.72% |
5,868
-299
| -5% | -$37.7K |
|
32
Novartis
NVS
$261B
| $728K | 0.68% |
8,339
-1,190
| -12% | -$103K |
|
33
Coca-Cola
KO
$380B
| $638K | 0.6% |
14,290
-940
| -6% | -$43.3K |
|
|
FITB
34
Fifth Third Bancorp
FITB
$49.6B
| $552K | 0.52% |
28,658
-400
| -1% | -$7.41K |
|
35
Merck
MRK
$355B
| $479K | 0.45% |
6,504
| – | – |
|
36
Cummins
CMI
$76.6B
| $470K | 0.44% |
2,717
-264
| -9% | -$42.2K |
|
37
Verisk Analytics
VRSK
$22.9B
| $465K | 0.44% |
2,736
-16
| -0.6% | -$2.53K |
|
38
Monro
MNRO
$400M
| $461K | 0.43% |
8,392
+236
| +3% | +$12.6K |
|
39
J.M. Smucker
SJM
$12.9B
| $434K | 0.41% |
4,105
| – | – |
|
40
Thermo Fisher Scientific
TMO
$225B
| $375K | 0.35% |
1,037
-49
| -5% | -$16.4K |
|
41
IBM
IBM
$229B
| $361K | 0.34% |
3,134
-507
| -14% | -$58.9K |
|
42
Union Pacific
UNP
$169B
| $339K | 0.32% |
2,009
-335
| -14% | -$53.7K |
|
43
Capri Holdings
CPRI
$1.58B
| $324K | 0.3% |
20,780
-1,878
| -8% | -$27.8K |
|
44
Fortune Brands Innovations
FBIN
$4.86B
| $322K | 0.3% |
5,909
-257
| -4% | -$12K |
|
|
45
RTX Corp
RTX
$266B
| $319K | 0.3% |
5,192
-3,071
| -37% | -$192K |
|
46
Omega Healthcare
OHI
$14.2B
| $293K | 0.28% |
9,865
| – | – |
|
47
Western Union
WU
$2.16B
| $255K | 0.24% |
11,815
-1,919
| -14% | -$39K |
|
48
Accenture
ACN
$113B
| – | – |
-124
| Closed | -$20K |
|
49
American Tower
AMT
$82.9B
| – | – |
-125
| Closed | -$27K |
|
50
Aon
AON
$64.2B
| – | – |
-200
| Closed | -$33K |
|
Similar funds
RWM
MWA
FFG
PA
PB
DFG
ACM
MVA
Brooktree Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Brooktree Capital Management held 104 positions worth $106M, up 23% from $86.3M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Brooktree Capital Management's Q2 2020 filing shows 11 increased, 29 reduced and 57 closed positions. The largest sale was Allergan plc, an estimated $325K.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- Brooktree Capital Management added most to DXC Technology in Q2 2020, an estimated $820K increase.
- Brooktree Capital Management's biggest Q2 2020 reduction was RTX Corp, cutting an estimated $192K.
- Brooktree Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $325K.
- Brooktree Capital Management's ten largest holdings make up 55% of its $106M portfolio in Q2 2020.
- Brooktree Capital Management opened 0 new positions and closed 57 in Q2 2020.
- Brooktree Capital Management's portfolio value rose 23% quarter-over-quarter to $106M.
Based on Brooktree Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.